TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27671175

Group type: EXPERIMENTAL
Intervention: Skeletonized left internal mammary artery (LIMA) harvesting
Number of subjects: 140

Group type: COMPARATOR
Intervention: Pedicled left internal mammary artery (LIMA) harvesting
Number of subjects: 140
Study: 24667153

Group type: EXPERIMENTAL
Intervention: 19% tax on sugar sweetened beverages (SSBs)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Regular prices (control condition)
Number of subjects: 102
Study: 22500389

Group type: EXPERIMENTAL
Intervention: Modified Shenqi Dihuang Decoction (MSDD) plus basic treatment of Western medicine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Basic treatment of Western medicine alone
Number of subjects: 118
Study: 20599813

Group type: EXPERIMENTAL
Intervention: Anodal-excitatory PPC tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Right PPC tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Right parietal tDCS without training
Number of subjects: 0
Study: 17290328

Group type: EXPERIMENTAL
Intervention: Cytokine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted therapies (tyrosine kinase and angiogenesis inhibitors)
Number of subjects: 0
Study: 12859305

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Abdominal wall lift
Number of subjects: 20
Study: 10762680

Group type: COMPARATOR
Intervention: Zinc phosphate cement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hand-mixed conventional glass-ionomer cement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Capsulated conventional glass-ionomer cement
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Resin composite cement
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: All cements
Number of subjects: 25
Study: 9172168

Group type: EXPERIMENTAL
Intervention: Increased risk for NIDDM (defined by higher 2 h glucose and insulin values on oral glucose tolerance testing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with NIDDM
Number of subjects: 0
Study: 8385741

Group type: EXPERIMENTAL
Intervention: Sulindac (150 mg orally twice a day for nine months)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (identical-appearing tablets)
Number of subjects: 22
Study: 3957482

Group type: EXPERIMENTAL
Intervention: Oral terbutaline (5 mg three times daily for two weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31567306

Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 30324580

Group type: EXPERIMENTAL
Intervention: AMDC‐USR (autologous muscle derived cells)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 27832689

Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 119

Group type: COMPARATOR
Intervention: Intravenous midazolam
Number of subjects: 119
Study: 22945813

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (video, workbook, minimal counseling)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control condition (brochure)
Number of subjects: 242
Study: 22364383

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2601

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention with drug-eluting stent (DES-PCI)
Number of subjects: 2601
Study: 20484325

Group type: EXPERIMENTAL
Intervention: Direct involvement by a community liaison/expert from the YMCA of Greater Indianapolis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Indirect involvement by a community liaison/expert from the YMCA of Greater Indianapolis
Number of subjects: 10
Study: 17942181

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (30 min, 5 days/week for 3 months)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 76
Study: 15882173

Group type: EXPERIMENTAL
Intervention: Preoperative combined chemoradiation (external‐beam radiotherapy to 45 Gy plus weekly cisplatin 50 mg/m2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NAIC) (cisplatin 50 mg/m2 and vincristin 1 mg/m2 every 7‐10 days for three courses)
Number of subjects: 60
Study: 14624765

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment (Genotropin, Pharmacia Corporation) for 6 months
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo treatment for 6 months
Number of subjects: 17
Study: 10471419

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 1415
Study: 8704017

Group type: EXPERIMENTAL
Intervention: MCT/LCT (medium chain triglycerides and long chain triglycerides) in a ratio of 1:1
Number of subjects: 0

Group type: COMPARATOR
Intervention: LCT (long chain triglycerides)
Number of subjects: 0
Study: 1877639

Group type: EXPERIMENTAL
Intervention: Toy Control Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toy activation only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microcomputer programs with screen reinforcement only
Number of subjects: 0
Study: 6283422

Group type: EXPERIMENTAL
Intervention: Amitriptyline (75 mg median dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30787078

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 94
Study: 27652610

Group type: COMPARATOR
Intervention: Standard prasugrel therapy (control group)
Number of subjects: 2600

Group type: EXPERIMENTAL
Intervention: De-escalating therapy (one-week prasugrel followed by one-week clopidogrel and PFT-guided maintenance therapy)
Number of subjects: 2600
Study: 26100474

Group type: EXPERIMENTAL
Intervention: Electrocautery of the patella
Number of subjects: 50

Group type: COMPARATOR
Intervention: No electrocautery of the patella (Control)
Number of subjects: 50
Study: 24963659

Group type: EXPERIMENTAL
Intervention: Mindfulness training for smokers
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cognitive-behavioral comparison group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (Mindfulness and Cognitive-behavioral)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mindfulness training for smokers (abstinent at post-test)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mindfulness training for smokers (correlation with negative affect)
Number of subjects: 18
Study: 22775317

Group type: EXPERIMENTAL
Intervention: rosiglitazone (Group 1, n = 8)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: glimepiride (Group 2, n = 7)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: vildagliptin or sitagliptin (Group 3, n = 16)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HbA1c <7.3%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: baseline HbA1c
Number of subjects: 31
Study: 19848211

Group type: EXPERIMENTAL
Intervention: Jiawei Yupingfeng Mixture (YPF)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transfer factor
Number of subjects: 200
Study: 17224344

Group type: EXPERIMENTAL
Intervention: Soy shakes
Number of subjects: 43

Group type: COMPARATOR
Intervention: Casein shakes
Number of subjects: 43
Study: 14979503

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rehabilitation
Number of subjects: 60
Study: 11481684

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Partial Sleep Deprivation (PSD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal Sleep (S)
Number of subjects: 15
Study: 9272342

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-cell vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-controlled, double-blind trials
Number of subjects: 0
Study: 8440856

Group type: EXPERIMENTAL
Intervention: Targeted risk abatement intervention (TI) strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care plus social visits (SV)
Number of subjects: 0
Study: 3819288

Group type: EXPERIMENTAL
Intervention: Corning 527 lens
Number of subjects: 103

Group type: COMPARATOR
Intervention: Plano lens
Number of subjects: 103

Group type: COMPARATOR
Intervention: Equivalent neutral density filter
Number of subjects: 103
Study: 29127842

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (0.5mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 55
Study: 27661022

Group type: EXPERIMENTAL
Intervention: Dry cupping on point P6 with activation of intermittent negative pressure
Number of subjects: 206

Group type: COMPARATOR
Intervention: Sham cupping without activation of negative pressure
Number of subjects: 206
Study: 24987051

Group type: EXPERIMENTAL
Intervention: EDTA chelation therapy
Number of subjects: 1708

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1708
Study: 22456591

Group type: EXPERIMENTAL
Intervention: Video self-observation (viewing themselves when ill)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Observation of others (viewing a same-sex actor displaying psychotic symptoms)
Number of subjects: 40
Study: 20202941

Group type: EXPERIMENTAL
Intervention: Upper limb exercises at 65% workload
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Upper limb exercises at 80% workload
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Upper limb exercises at 50% workload
Number of subjects: 24
Study: 18237361

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 18
Study: 15971396

Group type: EXPERIMENTAL
Intervention: Lay health worker intervention on 106 intervention farms
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group on 105 control farms
Number of subjects: 164
Study: 12357162

Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine 0.5 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine 2.0 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aminophylline 5 mg/kg
Number of subjects: 30
Study: 14557958

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine (PncOMPC)
Number of subjects: 1666

Group type: COMPARATOR
Intervention: Control vaccine (hepatitis B vaccine)
Number of subjects: 1666
Study: 9578008

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-dose barbiturates
Number of subjects: 16
Study: 7644238

Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac (1 mg/kg)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 87
Study: 2526633

Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B vaccine (HBVax II, MSD, 5 micrograms)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Plasma derived hepatitis B vaccine (HBVax, MSD, 10 micrograms)
Number of subjects: 40
Study: 136668

Group type: EXPERIMENTAL
Intervention: Mianserin hydrochloride (20 mg three times daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mianserin hydrochloride
Number of subjects: 0
Study: 31215721

Group type: EXPERIMENTAL
Intervention: Adapted intervention
Number of subjects: 44820

Group type: COMPARATOR
Intervention: Enhanced intervention
Number of subjects: 44820
Study: 28625367

Group type: EXPERIMENTAL
Intervention: Post-guideline period (after 2007 AHA guidelines)
Number of subjects: 3748

Group type: COMPARATOR
Intervention: Pre-guideline period (before 2007 AHA guidelines)
Number of subjects: 3748
Study: 26578109

Group type: EXPERIMENTAL
Intervention: Enhanced case management of asthma and COPD patients through strengthening of PHC facilities
Number of subjects: 734

Group type: COMPARATOR
Intervention: Standard care practices
Number of subjects: 734
Study: 22702846

Group type: COMPARATOR
Intervention: Etanercept monotherapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination etanercept and NB-UVB phototherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (etanercept monotherapy and combination therapy)
Number of subjects: 30
Study: 21785174

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) and erythropoietin (EPO) based intracoronary infusion of peripheral blood stem cells (PBSCs) after 5 days of G-CSF administration and EPO at the time of PBSCs injection
Number of subjects: 18
Study: 19111789

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 237

Group type: COMPARATOR
Intervention: Endometrial ablation
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Effective surgical treatment costing $40,000
Number of subjects: 237
Study: 16458799

Group type: EXPERIMENTAL
Intervention: Polygluconate co‐polymer (PGACP group, n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self‐reinforced poly‐L‐lactic acid polymer (PLLA group, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (PGACP and PLLA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PLLA group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PGACP group
Number of subjects: 40
Study: 15496639

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg daily for 6 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11783366

Group type: EXPERIMENTAL
Intervention: GnRH‐a long protocol (0.9 mg/day nasal spray starting on day 21)
Number of subjects: 109

Group type: COMPARATOR
Intervention: GnRH‐a short protocol (0.45 mg/day nasal spray starting on day 2)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: GnRH‐a long protocol and short protocol
Number of subjects: 109
Study: 9281927

Group type: EXPERIMENTAL
Intervention: Self-management program
Number of subjects: 55
Study: 8337991

Group type: EXPERIMENTAL
Intervention: Clobetasone butyrate 0.1% eye drops, two drops each eye, t.i.d. for 10 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo eye drops, two drops each eye, t.i.d. for 10 days
Number of subjects: 30
Study: 3688151

Group type: EXPERIMENTAL
Intervention: Deep Pressure Touch (DPT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Confinement without DPT (Control)
Number of subjects: 23
Study: 30153359

Group type: EXPERIMENTAL
Intervention: Simtuzumab 75 mg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Simtuzumab 125 mg
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Simtuzumab 75 mg and 125 mg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Advanced fibrosis
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Higher alkaline phosphatase
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Higher enhanced liver fibrosis score
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 234
Study: 28060063

Group type: EXPERIMENTAL
Intervention: 1.2 g/d of a triglyceride formulation of oral omega-3 fatty acids for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 400 mg/d vitamin E for 12 weeks
Number of subjects: 60
Study: 26209038

Group type: EXPERIMENTAL
Intervention: Sitagliptin (50 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glimepiride (1 mg/day) - Control
Number of subjects: 30
Study: 24180000

Group type: EXPERIMENTAL
Intervention: abacavir, zidovudine, lamivudine (arm A)
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: lopinavir–ritonavir, zidovudine–lamivudine (arm B)
Number of subjects: 730

Group type: COMPARATOR
Intervention: nevirapine–zidovudine–lamivudine (Obs arm)
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 730
Study: 21140383

Group type: EXPERIMENTAL
Intervention: 240 mg of EGb 761 once daily for 24 weeks
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo once daily for 24 weeks
Number of subjects: 410
Study: 19014338

Group type: EXPERIMENTAL
Intervention: docetaxel/estramustine
Number of subjects: 0

Group type: COMPARATOR
Intervention: zoledronic acid
Number of subjects: 0
Study: 17233285

Group type: EXPERIMENTAL
Intervention: Free Bone Graft (FBG)
Number of subjects: 65

Group type: COMPARATOR
Intervention: PEEK Cage
Number of subjects: 65
Study: 15596591

Group type: EXPERIMENTAL
Intervention: Submacular surgery
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1015
Study: 11449954

Group type: EXPERIMENTAL
Intervention: Solvent/detergent-treated intramuscular immunoglobulin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard intramuscular immunoglobulin
Number of subjects: 36
Study: 9610964

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone (2 mg/kg for 10 min)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 7946873

Group type: EXPERIMENTAL
Intervention: Tetanic stimulation at 25% of control twitch height (T0)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tetanic stimulation at 50% of control twitch height (T0)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tetanic stimulation at 75% of control twitch height (T0)
Number of subjects: 45
Study: 3260083

Group type: EXPERIMENTAL
Intervention: 0.05 mg propofol/kg per minute
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.10 mg propofol/kg per minute
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.15 mg propofol/kg per minute
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.20 mg propofol/kg per minute
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total propofol consumption
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Recovery time
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Arterial blood pressure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Side effects
Number of subjects: 40
Study: 29783942

Group type: EXPERIMENTAL
Intervention: Learning and Coping strategies (LC) plus Cardiac Rehabilitation (CR)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Cardiac Rehabilitation (CR) alone
Number of subjects: 244
Study: 28221177

Group type: EXPERIMENTAL
Intervention: Semirigid waved rod systems
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional rigid straight stiff rod systems
Number of subjects: 96
Study: 26333513

Group type: EXPERIMENTAL
Intervention: Plant sterols (2 g PS/d)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 24194839

Group type: EXPERIMENTAL
Intervention: Non-pneumatic Anti-Shock Garment (NASG) applied before transport to referral hospitals (RHs)
Number of subjects: 880

Group type: COMPARATOR
Intervention: Standard obstetric hemorrhage/shock protocols
Number of subjects: 880
Study: 21962416

Group type: EXPERIMENTAL
Intervention: Upright posture (90 minutes sitting and treadmill walking)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Supine posture (90 minutes recumbency)
Number of subjects: 9
Study: 18178379

Group type: EXPERIMENTAL
Intervention: Supplemented hypokinetic subjects (SHKSs) with daily supplementation of 0.7 mmol of calcium lactate per kilogram of body weight
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Unsupplemented hypokinetic subjects (UHKSs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supplemented active control subjects (SACSs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unsupplemented active control subjects (UACSs)
Number of subjects: 40
Study: 16813479

Group type: EXPERIMENTAL
Intervention: Rhythmic stabilization training
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Combination of isotonic exercises
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control
Number of subjects: 86
Study: 12708129

Group type: COMPARATOR
Intervention: Oral medication (Group I)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Insulin treatment (Group II)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Normal controls
Number of subjects: 80
Study: 10759770

Group type: EXPERIMENTAL
Intervention: HAART alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAART + IL-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAART alone or HAART + IL-2
Number of subjects: 0
Study: 8621989

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 3837

Group type: EXPERIMENTAL
Intervention: Propranolol with aspirin and/or coronary artery surgery
Number of subjects: 3837

Group type: EXPERIMENTAL
Intervention: Propranolol without aspirin and/or coronary artery surgery
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837
Study: 1423088

Group type: EXPERIMENTAL
Intervention: Annual mammography and physical examination (MP group)
Number of subjects: 39405

Group type: COMPARATOR
Intervention: Annual physical examination only (PO group)
Number of subjects: 39405
Study: 3891769

Group type: EXPERIMENTAL
Intervention: Smoking cessation (complete cessation for 14 subjects)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (33 matched controls continuing smoking)
Number of subjects: 66
Study: 31443663

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) prompt
Number of subjects: 15222

Group type: COMPARATOR
Intervention: No CDSS prompt (Control)
Number of subjects: 15222
Study: 30231484

Group type: EXPERIMENTAL
Intervention: Danggui Buxue Tang (DBT) supplementation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 28768071

Group type: COMPARATOR
Intervention: Hyperbaric oxygen (HBO₂)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 71
Study: 24183249

Group type: EXPERIMENTAL
Intervention: Electromagnetic (EM) navigator guidance without fluoroscopic support
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional fluoroscopic guidance
Number of subjects: 15
Study: 21831719

Group type: EXPERIMENTAL
Intervention: Pemetrexed-containing arms
Number of subjects: 2296

Group type: COMPARATOR
Intervention: Non-pemetrexed-containing arms
Number of subjects: 2296

Group type: EXPERIMENTAL
Intervention: Pemetrexed exposure
Number of subjects: 2296
Study: 19597910

Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 0